GT Biopharma Inc GTBP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/24/22 EDT
2.98UNCH (UNCH)
Volume
292,642
Close
2.98quote price arrow down-0.13 (-4.18%)
Volume
2,034,489
52 week range
1.51 - 16.45
Loading...
  • Open3.10
  • Day High3.29
  • Day Low2.85
  • Prev Close2.98
  • 52 Week High16.45
  • 52 Week High Date06/28/21
  • 52 Week Low1.51
  • 52 Week Low Date05/06/22

Key Stats

  • Market Cap90.89M
  • Shares Out30.50M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-2.3

KEY STATS

  • Open3.10
  • Day High3.29
  • Day Low2.85
  • Prev Close2.98
  • 52 Week High16.45
  • 52 Week High Date06/28/21
  • 52 Week Low1.51
  • 52 Week Low Date05/06/22
  • Market Cap90.89M
  • Shares Out30.50M
  • 10 Day Average Volume0.18M
  • Dividend-
  • Dividend Yield-
  • Beta0.46
  • YTD % Change-2.3

RATIOS/PROFITABILITY

  • EPS (TTM)-1.01
  • P/E (TTM)-2.96
  • Fwd P/E (NTM)-4.72
  • EBITDA (TTM)-33.955M
  • ROE (TTM)-160.94%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/11/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On GT Biopharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
GT Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of immuno-oncology products based on its Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. The Company's TriKE platform generate therapeutics designed to harness and enhance the cancer killing abilities of a patient's own natural killer (NK) cells. GTB-3550 is the Company's TriKE product candidate, which is a single-chain...
Michael Breen
Executive Chairman of the Board, Interim Chief Executive Officer
Manu Ohri
Chief Financial Officer
Address
8000 MARINA BLVD, SUITE 100
Brisbane, CA
94005
United States

Top Peers

SYMBOLLASTCHG%CHG
CRMD
CorMedix Inc
3.45-0.17-4.70%
TRVN
Trevena Inc
0.4181-0.0419-9.1087%
SCPH
scPharmaceuticals Inc
4.60-0.20-4.17%
SEEL
Seelos Therapeutics Inc
0.6611-0.0469-6.6243%
INFI
Infinity Pharmaceuticals Inc
0.7347-0.0991-11.8853%